An Open-Label, Long-Term Safety Study of SD-809 (Dutetra

  • Olson, Stephen C (PI)

Project: Research project

Project Details

Description

An Open-Label, Long-Term Safety Study of SD-809 (Dutetravenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
StatusFinished
Effective start/end date6/1/146/30/16

Funding

  • AUSPEX PHARMACEUTICALS, INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.